Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs Parenteral Steroids in COPD Exacerbations
NCT01865500Phase 4Completed
- Sponsor
- Atatürk University
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Atatürk University. Primary endpoint: Change of arterial blood gases (PaO2, PaCO2, pH). Started Jan 2013; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01865500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01865500.